![Kanishka Pothula](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kanishka Pothula
Directeur/Membre du Conseil chez
Exo Therapeutics, Inc.
Profil
Kanishka Pothula is currently Director at Exo Therapeutics, Inc. since 2021 and Managing Partner at Nextech Ventures (US) LLC since 2024.
Former roles include Managing Director at BVF Partners LP from 2012 to 2023, Director at Relay Therapeutics, Inc., Independent Director at Tango Therapeutics, Inc., and Associate at BroadOak Capital Partners LLC in 2011.
Education includes a graduate degree from Georgetown University in 2008 and an undergraduate degree from the University of California San Diego in 2006.
Postes actifs de Kanishka Pothula
| Sociétés | Poste | Début |
|---|---|---|
Exo Therapeutics, Inc.
 Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes | Directeur/Membre du Conseil | 05/10/2021 |
Nextech Ventures Us LLC
 Nextech Ventures Us LLC Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01/01/2024 |
Anciens postes connus de Kanishka Pothula
| Sociétés | Poste | Fin |
|---|---|---|
BVF Partners LP
 BVF Partners LP Investment ManagersFinance BVF generally pursues value-oriented investment strategies, investing primarily in the marketable securities issued by biotechnology companies. The focus of the BVF strategy is on fundamental, bottom-up analysis of individual issuers based on the theory that market mispricing exist because market prices do not incorporate all knowable economic and other relevant data. | Gestionnaire de Portefeuille-Actions | 01/01/2023 |
BroadOak Capital Partners LLC
 BroadOak Capital Partners LLC Investment ManagersFinance Broadoak capital partners LLC invests in companies located in the United States. The firm focuses on life sciences tools, diagnostics, and biopharma services sectors. It provides financing for growth stage capital requirements. | Corporate Officer/Principal | 31/12/2011 |
| TANGO THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
| RELAY THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
Formation de Kanishka Pothula
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
BVF Partners LP
BVF Partners LP Investment ManagersFinance BVF generally pursues value-oriented investment strategies, investing primarily in the marketable securities issued by biotechnology companies. The focus of the BVF strategy is on fundamental, bottom-up analysis of individual issuers based on the theory that market mispricing exist because market prices do not incorporate all knowable economic and other relevant data. | Finance |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BroadOak Capital Partners LLC
BroadOak Capital Partners LLC Investment ManagersFinance Broadoak capital partners LLC invests in companies located in the United States. The firm focuses on life sciences tools, diagnostics, and biopharma services sectors. It provides financing for growth stage capital requirements. | Finance |
Relay Therapeutics, Inc.
 Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
Nextech Ventures Us LLC
Nextech Ventures Us LLC Investment ManagersFinance Functions as an alternative investment manager | Finance |
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes | Health Technology |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
